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Abstract
Background: To investigate prospectively the patient-relevant outcome 7 years after total hip replacement (THR)
for osteoarthritis (OA).
Methods: 219 consecutive patients (120 women) with primary OA, mean age 71 (range 50-92) were assigned for
THR. They were examined preoperatively, at 3, 6, 12 months, and at 4, 5 and 7 years postoperatively with the self-
administered questionnaires SF-36 and WOMAC. Supplementary questions regarding postoperative complications,
general co-morbidity, social circumstances and patient satisfaction were asked at the three last follow-ups. A
reference group, 117 subjects (67 women), mean age 72 (range 52-92) without hip complaints were recruited from
the community and investigated at the same times.
Results: 151/170 (89%) of the patients and 65/74 (88%) of the reference group participated at the 7 year follow-
up. The best postoperative result was reported one year postoperatively. At the 7 year follow up there was a
significant difference between the patients and controls in SF-36 physical function (PF) and role physical (RP) but
not of WOMAC function. There was no difference in frequency of co-morbid conditions between those operated
and the reference group, but those operated were in greater need of walking aid (46% vs. 8% p < 0.0001) and
reported more regional and widespread pain (68% vs. 53% p < 0.05).
Conclusion: This study shows that in an unselected cohort the patients experience a similar health-related quality
of life as a reference group of a similar age and sex structure 7 years after THR except for general physical function
where the patients score worse.
Background
Total hip replacement (THR) is one of the most com-
mon interventions in orthopedic surgery. A continued
increase of incidence appears likely with a growing
elderly population who expects to live an active life. In a
review in Lancet 2007 [1]THR was identified as the
operation of the century since THR has revolutionized
the management of elderly patients with osteoarthritis
(OA) with very good long term results in terms of pros-
thetic survival and cost-effectiveness.
In patients suffering from severe osteoarthritis (OA)
total joint replacement is known to be the most effec-
tive treatment [2]and it offers the patient pain relief
as well as improved physical function [3,4]. The main
indication for THR is severe pain [5]. However,
patients’ expectations after THR have changed [6].
Today, many patients participate in broad range of
physical demanding activities and expect to live an
a c t i v el i f ei nt h ef u t u r e .W i t h i no r t h o p e d i cs u r g e r y
the assessment of effectiveness has traditionally
focused on the surgical and technical aspects.
Recently measurement of patient reported health out-
comes has provided an alternative source of valuable
information [7]. Numerous follow-up studies after
THR have been performed over the last decade with a
follow up time of one to two years with patient-
reported outcomes [6,8-13]. Information on patient
reported long term resultsi st h u sl i m i t e dw h e r e a s
there are numerous papers concerning long-term
prosthetic survival.
The main purpose of this study was to investigate
prospectively the patient-relevant outcome seven years
after THR for OA with a focus on pain and physical
function.
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Patients
Two hundred and nineteen patients (120 women, 55%),
mean age 71 years (range 50-92) with primary OA were
consecutively included in the study. All patients had a
unilateral THR performed at the department of Ortho-
pedics at Halmstad Central Hospital between September
1995 and October 1998 [4].
Reference group
For each patient, that was included during September
1997 to October 1998, 3 subjects were identified in the
National Population records. That resulted in 258 sub-
jects. The subjects were matched to the patients by age,
sex and municipality. The questionnaires were sent to
these 258 subjects with an explanatory cover letter. In
the cover letter they were told not to respond if they
had hip complaints. Hip complaints were defined as
pain or diminished range of motion in their hips.
One hundred and seventeen individuals (45%)
answered the first inquiry. Their mean age was 72
(range 52-92, 57% women, 43% men) [4]. One hundred
and forty one subjects did not answer the first inquiry.
Their mean age was 72 years (range 50-90, 52% women,
48% men). No reminder letters were sent as the number
was regarded as sufficient for comparison of groups.
Additional letters with the same questionnaires were
sent to these subjects at the same intervals as for the
patients.
Design of the study
Self report with the patient administered questionnaires
SF-36 and WOMAC was obtained preoperatively, at 3,
6, 12 months and after 4, 5 and 7 years postoperatively.
At the last three follow-ups supplementary questions
were asked.
Questionnaires
SF-36 is a widely used generic outcome measure [14]
and it consists of 8 domains; PH (physical function), RP
(role-physical), BP (bodily pain), GH (general health),
VT (vitality), SF (social functioning), RE (role-emotional)
and MH (mental health). The SF-36 is self-explanatory
and takes about 10 minutes to complete. The SF-36 is
scored from 0-100, 0 indicating extreme problems and
100 indicating no problems. The Acute Swedish version
of the SF-36 was used [15].
WOMAC (Western Ontario and McMaster Universi-
ties Osteoarthritis Index) was used as the disease speci-
fic outcome measurement (LK 3.0). WOMAC is well
known and a self administered instrument validated for
OA in the lower extremities and for evaluating outcome
after THR [16]. It consists of 24 items grouped in to
three categories: pain (five questions), stiffness (two
questions) and physical functi o n( s e v e n t e e nq u e s t i o n s ) .
It is reliable and valid for Swedish conditions [17]. To
enhance the interpretation WOMAC is transformed to a
0-100 worst to best scale [17-19]. Because this instru-
ment was not available and validated for Swedish condi-
tions when the study was started, it was used for the
last 92 patients included.
Additional questions
Questions concerning postoperative complications, preo-
perative and postoperative co-morbidity, social circum-
stances and patient satisfaction were asked at the 4, 5
and 7 year follow-up. The patients and the reference
group received the same questions except those relating
to postoperative complications.
Postoperative complications
Three questions dealt with serious postoperative compli-
cations, dislocation of the prosthesis, deep infection in
the hip joint and reoperation. The definition of post-
operative complication in this study referred to a posi-
tive answer in one of these three questions.
General co-morbidity
Fourteen questions were asked about intercurrent dis-
eases preoperatively and in the present situation
[20,21]. Questions were asked about the presence of 10
comorbid conditions or body areas with problems
(heart, hypertension, peripheral arteries, lung, diabetes,
neurological problems, cancer, ulcer, kidney disease,
vision).
Musculoskeletal co-morbidity
Two questions were asked about the need of walking
assistance and walking distance preoperatively and in
the present situation [22,23], two questions were asked
about the need for analgesics due to pain in the oper-
ated hip or due to pain elsewhere. One question was
asked about the experience of regional or widespread
pain lasting more than three months during the past 12
months [20]. One question was asked about joint repla-
cement in the contralateral hip or in the knees since the
THR. The final question concerned fractures in the
spine, wrist, hip or elsewhere.
Social circumstances
One question addressed living circumstances preopera-
tively and in the present situation. One question was
asked about the civil status and one about the main pro-
fession and the present profession or occupation.
Patient satisfaction
One question dealt with patient satisfaction after sur-
gery:” Overall, how satisfied are you with the result of
your hip replacement surgery”. The alternative answers
were: very satisfied, satisfied, dissatisfied, very
dissatisfied.
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Statistical analysis was performed using SPSS 17.0. For
comparison of preoperative and postoperative question-
naire data for the patients the Wilcoxon’ss i g n e dr a n k
test was used. Multiple logistic regression analysis was
taken in account to comparison between patients and
controls. Age, sex and SF-36 subscale were independent
variables and patient and controls dependent variables.
The municipality variable was not included as covariate
in the analyses since the controls were stratified after
belongings to municipality. Chi-square test was used
when comparing the patients and the controls using
walking aids, walking distance, number of co-morbid-
ities, low back pain, and widespread pain. Significance
level was set at 0.05.
Results
Of the 219 patients, 21 died during the 7 year follow up
period and 47 did not participate. Thus the result of
151 patients (83 women, 55%), with a mean age at sur-
gery of 70 years (range 50-88) are presented for a fol-
low-up time of 7 years (Table 1). Of the 117 subjects in
the reference group, 11 died during the follow-up period
and 41 declined participation. Thus the results for 65
(39 women, 60%) subjects, with a mean age at the start
of the study of 70 years (range 52-83) are presented
(Table 1).
Postoperative self-reported results
SF-36
The patients improved significantly in all subscales of
SF-36 between base line and 12 months postoperatively.
Between 12 months and 7 years postoperatively there
was a significant decline in all subscales except RE (role
emotional) (Table 2).
WOMAC
There was a significant improvement in all three sub-
scales of WOMAC between baseline and 12 months
postoperatively [4]. At the final follow-up there was no
significant decline in the WOMAC subscales compared
to 12 months (Table 3).
Postoperative complications
At seven years after surgery complications were reported
from 5 patients (3%). 4 patients suffered from a deep
infection and 2 of them were reoperated. 1 patient had
a dislocation of the prosthesis.
General comorbidity
19% of the patients reported 2 or more co-morbidities at
the 7 year follow up (Table 4).
The most common co-morbidity was hypertension
which 26% of the patients suffered from.
Musculoskeletal comorbidity
Almost half of the patients were in need of walking aids
at the last follow-up, though the majority reported a
walking distance more than 3 km. One third of the
patients suffered from low back pain and as many as
half of them from regional pain (Table 4).
Social circumstances
40% of the patients lived alone at the last follow-up. 54%
of the patients were homeowners and 45% lived in an
apartment.
Comparison between patients and controls
At the final follow-up there was a significant difference,
when adjusted for age and sex, between the patients and
the reference group in the subscale PF (physical func-
tion), VT (vitality) and RP (role physical) where the
patients scored worse (Table 5).
At that time there was no difference between the
patients and the referenceg r o u pi nW O M A Cp h y s i c a l
function but the patients reported more pain and more
stiffness than the reference group (Table 5).
A l m o s th a l fo ft h ep a t i e n t sw e r ei nn e e do fw a l k i n g
aid at the last follow-up compared to the reference
group where only 8% had those needs. However there
was no difference in walking ability between the two
groups (Table 4). There was no significant difference in
the presence of low-back pain but a difference in wide-
spread pain or regional pain between patients and con-
trols (Table 4).
Outcome in relation to preoperative pain and function
To examine the possible influence of preoperative pain
reported by SF-36 on postoperative SF-36 pain at 12
months, 4 years, 5 years and at the 7-year follow-up, the
patients were analyzed according to preoperative SF-36
pain score quartiles (≤ 22, 23-31, 32-41, ≥ 41). The
mean SF-36 pain score for each group at the different
assessments are shown in Figure 1. At the 12 months
follow-up the patients with a preoperative SF-36 pain
score in the lowest preoperative quartile (≤ 22) reached
almost the same level as the patients in the upper preo-
perative quartiles. At the final follow-up there was a
Table 1 Patients and controls during the study
Follow-up time baseline 4 years 5 years 7 years
Patients 219 198 170 151
Dead 8 13 21
Missing* 13 15 19 47
Controls 117 83 77 65
Dead 8 3 11
Missing* 26 6 9 41
*Missing due to dementia, unknown address or declined to participate.
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scores points (61 vs.71) (Figure 1).
The mean postoperative SF-36 PF score for the
patients were stratified according to their preoperative
SF-36 PF score quartiles (≤ 20, 21-30, 31-44, 44) (Fig-
ure 2). The patients in the lowest quartile had the
greatest improvement in mean PF score at the 7-year
follow-up, but was the group which declined the most
between 12 months and 7 years (64-44). The difference
between the patients in the lowest quartile and
the highest at the final follow up was 20 score points
(44 vs.64) (Figure 2).
Satisfaction
96% of the patients were satisfied in general with the
outcome at the seven year follow-up. As many as 95%
of the patients were satisfied with their ability to
practice leisure activities seven years after THR. 97%
were satisfied with their pain relief and improved physi-
cal function.
Discussion
Total hip replacement is a successful surgical interven-
tion. This study confirms previous knowledge of
Table 2 Preoperative, 12 months and 7 years postoperative mean scores and (standard deviations) for the SF-36
subscales, for the patients, mean age 70 (50-88)
Patients preoperative
(n = 151)
Patients 12 months
postoperative (n = 151)
p-value preop-12
months
Patients 7 years
Postoperative (n = 151)
p-value 12
months-7 years
SF-36 PF 31 (19.4) 68 (21.1) <0.001 54 (27.2) <0.001
SF-36 RP 9 (21.1) 61 (41.2) <0.001 45 (44.6) 0.001
SF-36 BP 31 (15.8) 75 (22.7) <0.001 63 (28.1) <0.001
SF-36 GH 68 (19.8) 73 (21.6) 0.008 63 (22.4) <0.001
SF-36 VT 49 (20.2) 73.4 (20.6) <0.001 59 (46.4) 0.003
SF-36 SF 63 (26.4) 88 (21.3) <0.001 62 (23.8) <0.001
SF-36 RE 37 (43.5) 74 (36.8) <0.001 81 (23.2) 0.10
SF-36 MH 70 (21.2) 83 (18.9) <0.001 79 (19.1) 0.03
The scale is 0-100, worst to best. The p-value is calculated between preoperative outcome and 12 months postoperative outcome and between 12 months
postoperative outcome and 7 years postoperative outcome.
Table 3 Preoperative, 12 months and 7 years postoperative mean scores and (standard deviations) for the three
WOMAC subscales, for the patients, mean age 70 (50-88)
Subscale Patients
preoperative (n = 75)
Patients 12 months
postoperative
p-value Patients 7 years
postoperative
p-value
WOMAC pain 44 (16.5) 85 (16.4) <0.001 86 (16.5) 0.69
WOMAC stiffness 38 (15.9) 77 (18.7) <0.001 78 (22.1) 0.63.
WOMAC function 38 (14.8) 79 (16.7) <0.001 76 (21.1) 0.12
The scale is 0-100, worst to best. The p-value is calculated between preoperative outcome and 12 months postoperative outcome and between 12 months
postoperative outcome and 7 years postoperative outcome
Table 4 Co-morbidities reported 7 years after THR
Patients N = 151 Controls N = 65 P value
Walking aids 46% 8% <0.001
Walking ability >3 km 59% 70% 0.15
Co-morbidities ≥ 2 19% 31% 0.08
Low back pain 29% 19% 0.17
Wide spread pain 15% 8% 0.05
Regional pain 53% 45% 0.05
Unilateral hip pain 20% 10% 0.07
Table 5 Final follow up (7 years) postoperative mean
scores and (standard deviations) of the SF-36 and
WOMAC subscales, for the patients, mean age 70 (50-88),
and the reference group, mean age 70 (50-83)
Subscale Patients 7 years
postoperative
(n = 151)
Reference
group 7 years
Postoperative
(n = 65)
p-value
SF-36 PF 54 (27.2) 69 (31.3) 0.01
SF-36 RP 45 (44.6) 60 (46.0) 0.05
SF-36 BP 63 (28.1) 69 (26.9) 0.19
SF-36 GH 63 (22.4) 62 (25.0) 0.94
SF-36 VT 59 (46.4) 72 (43.0) 0.05
SF-36 SF 62 (23.8) 65 (21.8) 0.36
SF-36 RE 81 (23.2) 79 (24.7) 0.53
SF-36 MH 79 (19.1) 72 (43.0) 0.90
WOMAC pain 86 (16.5) 91 (18.2) 0.05
WOMAC stiffness 78 (22.1) 89 (20.0) <0.001
WOMAC function 76 (21.1) 73 (23.8) 0.56
The p-value is calculated using a multiple logistic regression analysis, adjusted
for age and sex.
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improved health-related quality of life postoperatively
[7]. Patients who receive a THR experience almost the
same health related quality of life as a reference group
of similar age and sex structure apart from physical
function even seven years after surgery.
Most of the studies with patient reported data after
total joint replacements have a follow-up period of 1-2
years [6,8,10-13,24]. The patient reported data at that
time are generally good and coincide in many countries
with the last clinical assessment after surgery. The pre-
sent study is as far as we know one of few prospective
long-term follow-up studies of THR with a focus on
patient reported pain and physical function. In a pre-
vious study by Ng et al[25] they followed patients with
various preoperative diagnosis (92.5% OA) 5 years after
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Figure 1 SF-36 pain scores before and after THR. The mean SF-36 pain scores at the preoperative, 12 months, 4 year, 5 year and 7 years
follow-up according to preoperative SF-36 quartiles.
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Figure 2 SF-36 PF scores before and after TKR. The mean SF-36 PF scores at the preoperative, 12 months, 4 year, 5 year and 7 years follow-
up according to preoperative SF-36 quartiles.
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improvement was seen 6 months after surgery.
U n f o r t u n a t e l yt h e yd i dn o tm a k ea1y e a ra s s e s s m e n t
of outcome but it would probably be in accord to our
result. Furthermore, we had the possibility to follow a
reference group during the whole follow-up period. The
expected survival of the hip implant is at least 95% over
10 years http://www.jru.orthop.gu.se, hence, it would be
interesting to know how the patients experience the
results after such a long time. As far as we know there
are no such data presented.
Outcome in pain and physical function
The primary indication for THR is pain, although we
know that the patients expect a high degree of improve-
ment in physical function [6]. The present study shows
very satisfying results concerning pain relief, even in the
longer perspective, comparable with those of the matched
reference group. This is in contrast to results after total
knee replacement (TKR) where the patients report signifi-
cantly more pain after five years [26]. However, that is
based on one paper since there is still few long-term fol-
low up studies after TKR. It is well established that gains
in physical function after TKR and THR are delayed com-
pared with pain relief [7]. After one year the patients
report the same level of physical function as a matched
reference group (data not shown) but at the coming fol-
low-ups the patients decline significantly more than the
reference group. This may be due to the placebo effect of
surgery, since it has been shown in patients with OA that
there is a significant placebo effect, especially for self-
reported pain and function. The placebo effect is influ-
enced by the strength of the active treatment [27]. Surgery
and especially total joint replacements are considered to
be a very strong treatment with effect sizes >0.8[28]. How-
ever, the decline in physical function over the years is
more probably due to the musculoskeletal co-morbidity.
In our study there is a significant difference in the pre-
sence of regional and widespread pain between patients
and controls. The patients also reported more hip pain
which could be due to a generalized OA which proceeded
over years. The evidence of deteriorating physical function
over years makes it important to focus on the postopera-
tive rehabilitation [29,7]. Patients in the lowest quartile of
physical function had inferior results over time compared
with patients with a better baseline value. This is in accor-
dance with previous studies where a worse preoperative
physical function was shown to be a predictor of a worse
postoperative physical function [4,30,31].
A similar analysis of pain relief related to their base-
line values in SF-36 pain showed that the pain relief is
excellent and independent of the baseline value.
It is interesting to notice in our study that the patients
with the worst baseline score in SF-36 physical function
made the relatively greatest improvement after one year.
However, they are the same patients that make the lar-
gest decline to the last follow-up after seven years. It
seems as if total hip replacement for patients with a
very insufficient physical function only has a temporary
effect. Nevertheless, one has to be aware of the risk that
these results are an effect of the phenomenon of regres-
sion to the mean.
It has been shown in previous studies that disease
severity varies greatly at time of surgery [32] and that
there are large differences in preoperative pain and phy-
sical function between centers in different parts of the
world [33]. The population that is described in our
study seems to be representative since the patients’
reports scores somewhere in the middle. However, it is
still uncertain what effect it has on outcome.
Patient reported outcome measures
In the present study we found significant differences in
physical function compared to the reference group at
the final follow-up by using SF-36 but not by using
WOMAC. It seems probable that SF-36 has a better
ability to capture the general musculoskeletal co-mor-
bidity than WOMAC which focuses on the lower
extremity.
Satisfaction
Satisfaction is a complex phenomenon influenced by
many factors but especially by expectations and out-
come [34]. General satisfaction is, to our knowledge,
even more complex and should not be used as primary
outcome. It is too blunt of an instrument for that pur-
pose. In the present study as many as 96% of the
patients were satisfied with their THR as long as 7 years
after the intervention. It is notable that the satisfaction
concerning pain relief is comparable with the satisfac-
tion of improved physical function (96-97%). The results
are in contrast to a previous study of TKR where
approximately 60% of the patients were satisfied with
their pain relief after 5 years [26]. Thus, our study con-
firms what a number of previous studies have shown,
that it is easier to get satisfied patients and a better out-
come after THR than after TKR.
Conclusion
Total hip replacement for osteoarthritis is a successful
procedure. There is a marked change in most of the
measures from pre to post surgery. This study shows
that in an unselected cohort the patients experience a
similar health-related quality of life as a reference group
of a similar age, sex structure 7 years after THR except
for physical function where the patients score worse.
This may be explained by musculoskeletal co-morbid-
ities such as progress in generalized OA.
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